Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood-diverting catheter holds promise for stroke treatment

06.02.2004


American Stroke Association meeting report



A new catheter device that diverts some blood from the lower body to the brain appears safe for treating acute stroke and may significantly reduce stroke complications – even after a critical treatment window has lapsed.

The results of this experimental study were reported today at the American Stroke Association’s 29th International Stroke Conference.


"The device treats stroke by a unique approach that increases blood flow to the brain," said lead author Morgan S. Campbell III, M.D., director of interventional neurology at the Alabama Neurological Institute, in Birmingham. "Ten of the 15 patients who were conscious when they arrived at the hospital improved during the procedure, which is very impressive."

Campbell and his colleagues tested the safety and effectiveness of the device, called NeuroFlo, on patients who suffered ischemic strokes. Ischemic strokes occur when a blood clot blocks an artery, reducing blood flow and oxygen to part of the brain. Using two balloons attached to a catheter, NeuroFlo diverts some blood from the lower extremities and sends it to the upper body.

Not all the brain cells affected by an ischemic stroke die immediately, Campbell said. A large number of cells in the stroke area initially have the potential to recover if their blood supply is restored. In theory, increasing the volume of blood to these damaged brain cells should preserve some of them even more than three hours after a stroke onset.

Ischemic stroke patients who arrive within three hours of symptom onset can often be treated with clot-busting drugs. However, these clot busters are not recommended for use more than three hours after stroke onset.

"The blood volume theory has been studied before but no one had really shown that it actually works and makes a difference," Campbell said. "So it is very encouraging that the device can divert more oxygenated blood to the brain and that patients get better."

Campbell conducted the study while he was an assistant professor of neurology and radiology at The University of Texas Health Science Center at Houston. He and colleagues at eight medical centers in the United States, Turkey, Germany and Argentina studied 17 patients whose strokes had been in progress for three to 12 hours. The average time between stroke onset and the beginning of treatment was 7.5 hours.

Each patient had a NeuroFlo device inserted into an artery in the groin. The device was then threaded up to the abdominal aorta and positioned with collapsed balloons above and below the renal arteries. The balloons were then inflated to partially obstruct the aorta. The device was left in place for one hour.

"By blowing up these balloons and limiting the blood flow to the lower extremities, we shifted more of the blood flow up to the head," Campbell explained.

This greater volume of blood increased collateral flow, the flow of blood through smaller vessels in the brain. The collateral flow by-passed the blocked section of the artery that was causing the patient’s stroke, and brought needed oxygen to the cells downstream from the blockage.

The study’s primary intent was to test the device’s safety. Although two study participants died, their deaths were attributed to their strokes and not adverse effects of the device. Nor did people treated with the device suffer damage to their kidneys, heart or blood vessels.

The research team also evaluated the patients’ treatment response.

Twelve of 16 patients monitored with ultrasound had a 15 percent increase or more of their cerebral blood flow velocity, with an average boost of 25 percent. Ultrasound waves passing into the skull can measure blood flow velocity. Velocity is an indirect measure of blood flow volume.

The blood pressure in the arteries increased an average of only 6 percent overall and did not increase in five patients. "This shows the increased blood flow did not simply result from an increase in blood pressure but from an increase in blood volume," Campbell said. "This is the desired effect of the device."

The researchers also assessed the degree of deficit of the stroke patients. While undergoing their hour-long treatment, 10 of the 15 conscious patients (67 percent) showed significantly higher scores on the National Institutes of Health Stroke Scale, the most commonly used assessment tool in acute stroke. Thirty days after treatment, six of the 15 survivors had "good" physical function, on the modified Rankin scale, which rates disability.

The second phase of the study has begun enrollment. CoAxia, Inc., the device’s maker, will seek approval from the U.S. Food and Drug Administration to conduct a larger clinical trial.


Co-authors are James C. Grotta, M.D.; Camilo R. Gomez, M.D.; and Gazi Ozdemir, M.D.

Carole Bullock | EurekAlert!
Further information:
http://www.americanheart.org/

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

Im Focus: Newly proposed reference datasets improve weather satellite data quality

UMD, NOAA collaboration demonstrates suitability of in-orbit datasets for weather satellite calibration

"Traffic and weather, together on the hour!" blasts your local radio station, while your smartphone knows the weather halfway across the world. A network of...

Im Focus: Repairing defects in fiber-reinforced plastics more efficiently

Fiber-reinforced plastics (FRP) are frequently used in the aeronautic and automobile industry. However, the repair of workpieces made of these composite materials is often less profitable than exchanging the part. In order to increase the lifetime of FRP parts and to make them more eco-efficient, the Laser Zentrum Hannover e.V. (LZH) and the Apodius GmbH want to combine a new measuring device for fiber layer orientation with an innovative laser-based repair process.

Defects in FRP pieces may be production or operation-related. Whether or not repair is cost-effective depends on the geometry of the defective area, the tools...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Multiregional brain on a chip

16.01.2017 | Power and Electrical Engineering

New technology enables 5-D imaging in live animals, humans

16.01.2017 | Information Technology

Researchers develop environmentally friendly soy air filter

16.01.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>